{"id":"W2767918609","doi":"10.1093/annonc/mdx429.004","title":"ARIEL4: An international, randomised phase 3 study of rucaparib vs chemotherapy as treatment for BRCA1- or BRCA2-mutated, relapsed ovarian cancer","year":2017,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; BRCA mutation; Ovarian cancer; Internal medicine; Oncology; Olaparib; Chemotherapy; Regimen; Progressive disease; Cancer; PARP inhibitor; Chemotherapy regimen; Poly ADP ribose polymerase; Genetics; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002720042,0.002478276,0.003716507,0.0007693662,0.0005281558,0.001669843,0.001708672,0.002565794,0.01459876],"category_scores_gemma":[0.002460281,0.0009502066,0.003276251,0.0006888194,0.001715745,0.001826886,0.0006284452,0.006775798,0.002260757],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001175963,"about_ca_system_score_gemma":0.001358167,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001724854,"about_ca_topic_score_gemma":0.003969792,"domain_scores_codex":[0.9990201,0.0005862753,0.00003638713,0.0001383455,0.00005362689,0.0001652275],"domain_scores_gemma":[0.9986886,0.0004869561,0.0002260288,0.000122242,0.00004884307,0.0004272486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9750108,0.005646199,0.0003113287,0.0004477766,0.0009756506,0.00003089429,0.0000429785,0.0005541114,0.001937311,0.000171924,0.0009351015,0.01393585],"study_design_scores_gemma":[0.9450088,0.05221293,0.0007270701,0.00002532456,0.0004051175,0.00003141617,0.00002194475,0.0003450012,0.0002550832,0.0002110763,0.0007387666,0.0000174166],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9713958,0.008895709,0.001656706,0.002292145,0.001587694,0.004462247,0.003376933,0.000460071,0.005872627],"genre_scores_gemma":[0.96627,0.005463138,0.00321998,0.002945608,0.0009577705,0.00575482,0.003620952,0.000173064,0.01159464],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01459876,"threshold_uncertainty_score":0.04883772,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2083637478743436,"score_gpt":0.5285145537961317,"score_spread":0.320150805921788,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}